Video Hero Poster

Beyond fulfilment

Contact Us

Boucher & Muir Pty Ltd (BNM), an ADVANZ PHARMA company, is an innovative pharmaceutical company delivering sustainable value across our product portfolio to customers in Australia, New Zealand and the South Pacific Islands.

BNM commenced business in 1957, a family owned and operated company. As an ADVANZ PHARMA company, BNM continues to espouse strong family values and, with its experienced and talented team, is committed to helping patients lead healthier, better lives by enabling patients and healthcare providers to access high-quality, niche, established medicines.

We do this by revitalising and innovating niche, established medicines that without our focus, may otherwise not be available to patients. Our customers, partners and patients value us because we go further than simply meeting their need for quality medicines and medical products. We believe in close, collaborative partnerships that build trust and inspire better solutions.

Our Portfolio —

Our portfolio consists of Amdipharm, Mercury and BNM Group Products in both Australia and New Zealand

All products under the Amdipharm and Mercury banner are owned by ADVANZ PHARMA with the majority of the BNM Group products both in Australia and New Zealand being in licensed.

Careers & Culture —

We like to think we’re a breath of fresh air. We’re a business that’s not afraid to evolve. To rethink the way we work. To strive for more. In fact, our forward-thinking approach is one of the reasons we branded last year.

Responsibility —

ADVANZ PHARMA takes its Environmental, Social & Governance (ESG) responsibilities very seriously. We have been sponsoring a number of charities for many years and have an active environmental programme.

Our Partnerships —

ADVANZ PHARMA has a long history of collaboration whether it is working with licensing opportunities, acquiring new products or distribution logistics, we work with a multitude of partners across the world.

About Us —

Boucher & Muir Pty Ltd (BNM), an ADVANZ PHARMA company, is an innovative pharmaceutical company delivering sustainable value across our product portfolio to customers…

BNM commenced business in 1957, a family owned and operated company. As an ADVANZ PHARMA company, BNM continues to espouse strong family values and, with its experienced and talented team, strives to go beyond the fulfilment of orders for medicines and medical products, to be a trusted and respected partner in protecting the health of families.

Latest News —

Image for ADVANZ PHARMA completes acquisition of Intercept’s business in Europe, Canada, and all other markets outside of the U.S.

Press Releases — 01 Jul 2022

ADVANZ PHARMA completes acquisition of Intercept’s business in Europe, Canada, and all other markets outside of the U.S.

Learn more
Image for ADVANZ PHARMA to acquire Intercept’s business in Europe, Canada, and all other markets outside of the U.S.

Press Releases — 05 May 2022

ADVANZ PHARMA to acquire Intercept’s business in Europe, Canada, and all other markets outside of the U.S.

Learn more
Image for Steffen Wagner assumes his position as new Chief Executive Officer at ADVANZ PHARMA

Press Releases — 31 Mar 2022

Steffen Wagner assumes his position as new Chief Executive Officer at ADVANZ PHARMA

Learn more
Image for Cidron Aida Finco S.à r.l.  Successful pricing of €175.0 million 5% Senior Secured Notes due 2028

Press Releases — 20 Jan 2022

Cidron Aida Finco S.à r.l. Successful pricing of €175.0 million 5% Senior Secured Notes due 2028

Learn more
Image for Cidron Aida Finco S.à r.l. Proposed Offering of €150 million 5% Senior Secured Notes due 2028

Press Releases — 17 Jan 2022

Cidron Aida Finco S.à r.l. Proposed Offering of €150 million 5% Senior Secured Notes due 2028

Learn more
Image for Allecra Therapeutics and ADVANZ PHARMA Sign Exclusive License and Supply Agreement for Allecra’s Antibiotic Cefepime/enmetazobactam in Europe

Allecra Therapeutics and ADVANZ PHARMA Sign Exclusive License and Supply Agreement for Allecra’s Antibiotic Cefepime/enmetazobactam in Europe

Learn more